Polymeric nanoparticles for targeted drug delivery system for cancer therapy

Materials Science and Engineering C

Volumn 60, Issue , 2016, Pages 569-578

  Masood, Farha ^a  

^a Department of Electrical Computer Engineering   (Pakistan)

Author keywords

Anticancer drug; Drug delivery; Nanoparticles; Polymer; Receptor; Site specific target

Indexed keywords

BIOCOMPATIBILITY; BIODEGRADABILITY; CONTROLLED DRUG DELIVERY; DISEASES; DRUG DELIVERY; NANOPARTICLES; ONCOLOGY; POLYMERS; TISSUE; TISSUE ENGINEERING;

ANTICANCER DRUG; POLY LACTIC-CO-GLYCOLIC ACID; POLYHYDROXYALKANOATES; POLYMERIC NANOPARTICLES; RECEPTOR; SITE-SPECIFIC; TARGETED DELIVERY SYSTEMS; TARGETED DRUG DELIVERY SYSTEMS;

TARGETED DRUG DELIVERY;

ANTINEOPLASTIC AGENT; NANOPARTICLE; POLYMER;

ANIMAL; CHEMISTRY; DRUG DELIVERY SYSTEM; HUMAN; NEOPLASMS; PROCEDURES;

ANIMALS; ANTINEOPLASTIC AGENTS; DRUG DELIVERY SYSTEMS; HUMANS; NANOPARTICLES; NEOPLASMS; POLYMERS;

EID: 84991325553     PISSN: 09284931     EISSN: 18730191     Source Type: Journal    
DOI: 10.1016/j.msec.2015.11.067     Document Type: Review

References (125)

1. J. Ferlay, I. Soerjomataram, M. Ervik, R. Dikshit, S. Eser, C. Mathers, M.P.D. Rebelo, D. Forman, and F. Bray GLOBOCAN 2012 v1.0, cancer incidence and mortality worldwide: IARC cancerbase. No. 11 [Internet]. Lyon, France Int. Agency Res. Cancer 11 2013 http://globocan.iarc.f
2. K. Cho, X. Wang, S. Nie, Z.G. Chen, and D.M. Shin Therapeutic nanoparticles for drug delivery in cancer Clin. Cancer Res. 14 2008 1310 1316
3. G. Soni, and K.S. Yadav Applications of nanoparticles in treatment and diagnosis of leukemia Mater. Sci. Eng. C. Mater. Biol. Appl. 47 2015 156 164
4. C. Pinto Reis, R.J. Neufeld, A.J. Ribeiro, F. Veiga, and I. Nanoencapsulation Methods for preparation of drug-loaded polymeric nanoparticles Nanomedicine 2 2006 8 21
5. J.P. Rao, and K.E. Geckeler Polymer nanoparticles: preparation techniques and size-control parameters Prog. Polym. Sci. 36 2011 887 913
6. S.L. Pal, U. Jana, P.K. Manna, G.P. Mohanta, and R. Manavalan Nanoparticle: An Overview of Preparation and Characterization. 01 2011 228 234
7. N. Yoneki, and et al. One-pot facile preparation of PEG-modified PLGA nanoparticles: effects of PEG and PLGA on release properties of the particles Colloids Surf. A Physicochem. Eng. Asp. 469 2015 66 72
8. S. Surassmo, and et al. Surface modification of PLGA nanoparticles by carbopol to enhance mucoadhesion and cell internalization Colloids Surf. B: Biointerfaces 130 2015 229 236
9. J.B.G. Yaméogo, and et al. Self-assembled biotransesterified cyclodextrins as potential artemisinin nanocarriers. II: in vitro behavior toward the immune system and in vivo biodistribution assessment of unloaded nanoparticles Eur. J. Pharm. Biopharm. 88 2014 683 694
10. C.I.C. Crucho, and M.T. Barros Formulation of functionalized PLGA polymeric nanoparticles for targeted drug delivery Polymer (Guildf). 68 41-46 2015
11. Z. Zhou, A. Badkas, M. Stevenson, J.-Y. Lee, and Y.-K. Leung Herceptin conjugated PLGA-PHis-PEG pH sensitive nanoparticles for targeted and controlled drug delivery Int. J. Pharm. 487 2015 81 90
12. H. Fessi, F. Puisieux, J.P. Devissaguet, N. Ammoury, and S. Benita Nanocapsule formation by interfacial polymer deposition following solvent displacement Int. J. Pharm. 55 1989 R1 R4
13. X. Tang, and et al. Co-delivery of docetaxel and poloxamer 235 by PLGA-TPGS nanoparticles for breast cancer treatment Mater. Sci. Eng. C. Mater. Biol. Appl. 49 2015 348 355
14. M. Kalani, and R. Yunus Effect of supercritical fluid density on nanoencapsulated drug particle size using the supercritical antisolvent method Int. J. Nanomedicine 7 2012 2165 2172
15. 2 Powder Technol. 268 2014 118 125
16. 2 system for nanoparticle preparation of indomethacin Int. J. Pharm. 386 2010 243 248
17. X. Song, and et al. PLGA nanoparticles simultaneously loaded with vincristine sulfate and verapamil hydrochloride: systematic study of particle size and drug entrapment efficiency Int. J. Pharm. 350 2008 320 329
18. A. Dalpiaz, and et al. Application of the 'in-oil nanoprecipitation' method in the encapsulation of hydrophilic drugs in PLGA nanoparticles J. Drug Deliv. Sci. Technol. 2015 10.1016/j.jddst.2015.07.020
19. W. Guo, P. Quan, L. Fang, D. Cun, and M. Yang Sustained release donepezil loaded PLGA microspheres for injection: preparation, in vitro and in vivo study J. Pharm. Sci. 10 2015 405 414
20. M. García-Díaz, C. Foged, and H.M. Nielsen Improved insulin loading in poly(lactic-co-glycolic) acid (PLGA) nanoparticles upon self-assembly with lipids Int. J. Pharm. 482 2015 84 91
21. H. Wang, and et al. Hyaluronic acid-decorated dual responsive nanoparticles of pluronic F127, PLGA, and chitosan for targeted co-delivery of doxorubicin and irinotecan to eliminate cancer stem-like cells Biomaterials 72 2015 74 89
22. L. Mayol, and et al. Curcumin loaded PLGA-poloxamer blend nanoparticles induce cell cycle arrest in mesothelioma cells Eur. J. Pharm. Biopharm. 93 2015 37 45
23. S. Naahidi, and et al. Biocompatibility of engineered nanoparticles for drug delivery J. Control. Release 166 2013 182 194
24. X. Li, and et al. Self-assembled polymeric micellar nanoparticles as nanocarriers for poorly soluble anticancer drug ethaselen Nanoscale Res. Lett. 4 2009 1502 1511
25. U. Edlund, and A. Albertsson Degradable polymer microspheres for controlled Drug Delivery. 157 2002
26. F. Masood, and et al. Encapsulation of Ellipticine in poly- (3-hydroxybutyrate-co-3-hydroxyvalerate) based nanoparticles and its in vitro application Mater. Sci. Eng. C 33 2013 1054 1106
27. M. Shah, M. Imran, M. Hwan, M. Ok, and S. Chul Amphiphilic PHA - mPEG copolymeric nanocontainers for drug delivery: preparation, characterization and in vitro evaluation Int. J. Pharm. 400 2010 165 175
28. A. Kumari, S.K. Yadav, and S.C. Yadav Biodegradable polymeric nanoparticles based drug delivery systems Colloids Surf. B: Biointerfaces 75 2010 1 18
29. L. Brannon-Peppas, and J.O. Blanchette Nanoparticle and targeted systems for cancer therapy Adv. Drug Deliv. Rev. 56 2004 1649 1659
30. M.J. Akhtar, M. Ahamed, H.a. Alhadlaq, S.a. alrokayan, and S. kumar Targeted anticancer therapy: overexpressed receptors and nanotechnology Clin. Chim. Actinomycetes 436 2014 78 92
31. M.K. Yu, J. Park, and S. Jon Targeting strategies for multifunctional nanoparticles in cancer imaging and therapy Theranostics 2 2012 3 44
32. C.Y. Ang, S.Y. Tan, and Y. Zhao Recent advances in biocompatible nanocarriers for delivery of chemotherapeutic cargoes towards cancer therapy Org. Biomol. Chem. 12 2014 4776 4806
33. N. Karra, and et al. Antibody conjugated PLGA nanoparticles for targeted delivery of paclitaxel palmitate: efficacy and biofate in a lung cancer mouse model Small 9 2013 4221 4236
34. J. Lee, and et al. Tumor-specific hybrid polyhydroxybutyrate nanoparticle: surface modification of nanoparticle by enzymatically synthesized functional block copolymer Bioorg. Med. Chem. Lett. 21 2011 2941 2944
35. J. Guo, and et al. Aptamer-functionalized PEG-PLGA nanoparticles for enhanced anti-glioma drug delivery Biomaterials 32 2011 8010 8020
36. Y. Yao, and et al. A specific drug targeting system based on polyhydroxyalkanoate granule binding protein PhaP fused with targeted cell ligands Biomaterials 29 2008 4823 4830
37. R. Singh, and J.W. Lillard Nanoparticle-based targeted drug delivery Exp. Mol. Pathol. 86 2009 215 223
38. S.D. Steichen, M. Caldorera-Moore, and N. Peppas A review of current nanoparticle and targeting moieties for the delivery of cancer therapeutics Eur. J. Pharm. Sci. 48 2013 416 427
39. F. Masood, T. Yasin, and A. Hameed Polyhydroxyalkanoates - what are the uses? Current challenges and perspectives Crit. Rev. Biotechnol. 8551 2014 1 8
40. W.B. Liechty, D.R. Kryscio, B.V. Slaughter, and N.A. Peppas Polymers for drug delivery systems Annual Review of Chemical and Biomolecular Engineering 1 2010 149 173
41. Y. Duan, X. Sun, T. Gong, Q. Wang, and Z. Zhang Preparation of DHAQ-loaded mPEG-PLGA-mPEG nanoparticles and evaluation of drug release behaviors in vitro/in vivo J. Mater. Sci. Mater. Med. 17 2006 509 516
42. F. Masood, and et al. Synthesis of poly-(3-hydroxybutyrate-co-12 mol % 3-hydroxyvalerate) by Bacillus cereus FB11: its characterization and application as a drug carrier J. Mater. Sci. Mater. Med. 24 2013 1927 1937
43. M. Shah, N. Ullah, M.H. Choi, M.O. Kim, and S.C. Yoon Amorphous amphiphilic P(3HV-co-4HB)-b-mPEG block copolymer synthesized from bacterial copolyester via melt transesterification: nanoparticle preparation, cisplatin-loading for cancer therapy and in vitro evaluation Eur. J. Pharm. Biopharm. 80 2012 518 527
44. C. Vilos, and et al. Paclitaxel-PHBV nanoparticles and their toxicity to endometrial and primary ovarian cancer cells Biomaterials 34 2013 4098 4108
45. X.Y. Lu, Y. Zhang, and L. Wang Preparation and in vitro drug-release behavior of 5-fluorouracil-loaded poly(hydroxybutyrateco-hydroxyhexanoate) nanoparticles and microparticles J. Appl. Polym. Sci. 116 2010 2944 2950
46. E. KIlIçay, and et al. Preparation and characterization of poly(3-hydroxybutyrate-co-3-hydroxyhexanoate) (PHBHHX) based nanoparticles for targeted cancer therapy Eur. J. Pharm. Sci. 44 2011 310 320
47. C. Zhang, and et al. Folate-mediated poly(3-hydroxybutyrate-co-3-hydroxyoctanoate) nanoparticles for targeteing drug delivery Eur. J. Pharm. Biopharm. 76 2010 10 16
48. F. Danhier, and et al. Paclitaxel-loaded PEGylated PLGA-based nanoparticles: in vitro and in vivo evaluation J. Control. Release 133 2009 11 17
49. T. Khuroo, and et al. Topotecan-tamoxifen duple PLGA polymeric nanoparticles: investigation of in vitro, in vivo and cellular uptake potential Int. J. Pharm. 473 2014 384 394
50. M.H. Cháirez-Ramírez, and et al. Morphological and release characterization of nanoparticles formulated with poly (dl-lactide-co-glycolide) (PLGA) and lupeol: in vitro permeability and modulator effect on NF-κB in caco-2 cell system stimulated with TNF-α Food Chem. Toxicol. 2015 10.1016/j.fct.2015.08.003
51. L.R. Jaidev, U.M. Krishnan, and S. Sethuraman Gemcitabine loaded biodegradable PLGA nanospheres for in vitro pancreatic cancer therapy Mater. Sci. Eng. C. Mater. Biol. Appl. 47 2015 40 47
52. K. Derakhshandeh, M. Erfan, and S. Dadashzadeh Encapsulation of 9-nitrocamptothecin, a novel anticancer drug, in biodegradable nanoparticles: factorial design, characterization and release kinetics Eur. J. Pharm. Biopharm. 66 2007 34 41
53. H. Wang, and et al. Enhanced anti-tumor efficacy by co-delivery of doxorubicin and paclitaxel with amphiphilic methoxy PEG-PLGA copolymer nanoparticles Biomaterials 32 2011 8281 8290
54. D. Le Broc-Ryckewaert, and et al. Development of innovative paclitaxel-loaded small PLGA nanoparticles: study of their antiproliferative activity and their molecular interactions on prostatic cancer cells Int. J. Pharm. 454 2013 712 719
55. G. Mattheolabakis, E. Taoufik, S. Haralambous, M.L. Roberts, and K. Avgoustakis In vivo investigation of tolerance and antitumor activity of cisplatin-loaded PLGA-mPEG nanoparticles Eur. J. Pharm. Biopharm. 71 2009 190 195
56. N. Schleich, and et al. Dual anticancer drug/superparamagnetic iron oxide-loaded PLGA-based nanoparticles for cancer therapy and magnetic resonance imaging Int. J. Pharm. 447 2013 94 101
57. A.K. Jain, K. Thanki, and S. Jain Co-encapsulation of tamoxifen and quercetin in polymeric nanoparticles: implications on oral bioavailability, antitumor efficacy, and drug-induced toxicity Mol. Pharm. 10 2013 3459 3474
58. J.M. Chan, and et al. PLGA-lecithin-PEG core-shell nanoparticles for controlled drug delivery Biomaterials 30 2009 1627 1634
59. L. Martín-Banderas, and et al. In vitro and in vivo evaluation of Δ9-tetrahidrocannabinol/PLGA nanoparticles for cancer chemotherapy Int. J. Pharm. 487 2015 205 212
60. C. Chittasupho, and et al. ICAM-1 targeting of doxorubicin-loaded PLGA nanoparticles to lung epithelial cells Eur. J. Pharm. Sci. 37 2009 141 150
61. C. Liang, and et al. Improved therapeutic effect of folate-decorated PLGA-PEG nanoparticles for endometrial carcinoma Bioorg. Med. Chem. 19 2011 4057 4066
62. N.L. Dhas, P.P. Ige, and R.R. Kudarha Design, optimization and in-vitro study of folic acid conjugated-chitosan functionalized PLGA nanoparticle for delivery of bicalutamide in prostate cancer Powder Technol. 283 2015 234 245
63. W.-C. Su, W.-P. Su, Cheng, Shieh, and Yeh PLGA nanoparticles codeliver paclitaxel and Stat3 siRNA to overcome cellular resistance in lung cancer cells Int. J. Nanomed. 4269 2012 10.2147/IJN.S33666
64. G. Luo, and et al. LyP-1-conjugated nanoparticles for targeting drug delivery to lymphatic metastatic tumors Int. J. Pharm. 385 2010 150 156
65. Y. Cui, Q. Xu, P.K.-H. Chow, D. Wang, and C.-H. Wang Transferrin-conjugated magnetic silica PLGA nanoparticles loaded with doxorubicin and paclitaxel for brain glioma treatment Biomaterials 34 2013 8511 8520
66. A. Jain, and et al. Surface engineered polymeric nanocarriers mediate the delivery of transferrin-methotrexate conjugates for an improved understanding of brain cancer Acta Biomater. 24 2015 140 151
67. S. Dhar, F.X. Gu, R. Langer, O.C. Farokhzad, and S.J. Lippard Targeted delivery of cisplatin to prostate cancer cells by aptamer functionalized Pt(IV) prodrug-PLGA-PEG nanoparticles Proc. Natl. Acad. Sci. U. S. A. 105 2008 17356 17361
68. C. Chittasupho, K. Lirdprapamongkol, P. Kewsuwan, and N. Sarisuta Targeted delivery of doxorubicin to A549 lung cancer cells by CXCR4 antagonist conjugated PLGA nanoparticles Eur. J. Pharm. Biopharm. 2014 10.1016/j.ejpb.2014.06.020
69. F. Danhier, and et al. Targeting of tumor endothelium by RGD-grafted PLGA-nanoparticles Methods Enzymol. 508 2012 157 175
70. L. Li, and et al. Epithelial cell adhesion molecule aptamer functionalized PLGA-lecithin-curcumin-PEG nanoparticles for targeted drug delivery to human colorectal adenocarcinoma cells Int. J. Nanomedicine 9 2014 1083 1096
71. H. Chen, and et al. Preparation and characterization of PE38KDEL-loaded anti-HER2 nanoparticles for targeted cancer therapy J. Control. Release 128 2008 209 216
72. A. Aravind, and et al. Aptamer conjugated paclitaxel and magnetic fluid loaded fluorescently tagged PLGA nanoparticles for targeted cancer therapy J. Magn. Magn. Mater. 344 2013 116 123
73. S. Aggarwal, S. Yadav, and S. Gupta EGFR targeted PLGA nanoparticles using gemcitabine for treatment of pancreatic cancer J. Biomed. Nanotechnol. 7 2011 137 138
74. S. Narayanan, and et al. Sequential release of epigallocatechin gallate and paclitaxel from PLGA-casein core/shell nanoparticles sensitizes drug-resistant breast cancer cells Nanomed. Nanotechnol. Biol. Med. 11 2015 1399 1406
75. K. Wei, X. Peng, and F. Zou Folate-decorated PEG-PLGA nanoparticles with silica shells for capecitabine controlled and targeted delivery Int. J. Pharm. 464 2014 225 233
76. K.K. Vangara, J.L. Liu, and S. Palakurthi Hyaluronic acid-decorated PLGA-PEG nanoparticles for targeted delivery of SN-38 to ovarian cancer Anticancer Res. 33 2013 2425 2434
77. P. Kocbek, N. Obermajer, M. Cegnar, J. Kos, and J. Kristl Targeting cancer cells using PLGA nanoparticles surface modified with monoclonal antibody J. Control. Release 120 2007 18 26
78. C. Varan, and E. Bilensoy Development of implantable hydroxypropyl-β-cyclodextrin coated polycaprolactone nanoparticles for the controlled delivery of docetaxel to solid tumors J. Incl. Phenom. Macrocycl. Chem 1-7 2014 10.1007/s10847-014-0422-6
79. Y. Cirpanli, E. Bilensoy, a. Lale doʇan, and S. caliş Comparative evaluation of polymeric and amphiphilic cyclodextrin nanoparticles for effective camptothecin delivery. Eur. J. Pharm. Biopharm. 73 2009 82 89
80. F. Perret, M. Duffour, Y. Chevalier, and H. Parrot-Lopez Design, synthesis, and in vitro evaluation of new amphiphilic cyclodextrin-based nanoparticles for the incorporation and controlled release of acyclovir Eur. J. Pharm. Biopharm. 83 2013 25 32
81. Q. Miao, and et al. Construction of hydroxypropyl-β-cyclodextrin copolymer nanoparticles and targeting delivery of paclitaxel J. Nanoparticle Res. 14 2012 1043
82. L.Y. Qiu, and Y.H. Bae Polymer architecture and drug delivery Pharm. Res. 23 2006 1 30
83. S.-W. Peng, and et al. An assessment of the risks of carcinogenicity associated with polyhydroxyalkanoates through an analysis of DNA aneuploid and telomerase activity Biomaterials 32 2011 2546 2555
84. M. Potter, and A. Steinbuchel Poly(3-hydroxybutyrate) granule-associated proteins: Impacts on poly(3-hydroxybutyrate) synthesis and degradation Biomacromolecules 6 2005 552 560
85. M. Studenovsky, and et al. Polymer carriers for anticancer drugs targeted to EGF receptor Macromol. Biosci. 12 2012 1714 1720
86. P. Oberoi, R.A. Jabulowsky, H. Bähr-Mahmud, and W.S. Wels EGFR-targeted granzyme B expressed in NK cells enhances natural cytotoxicity and mediates specific killing of tumor cells PLoS ONE 8 2013
87. J. Pan, and S.S. Feng Targeting and imaging cancer cells by folate-decorated, quantum dots (QDs)- loaded nanoparticles of biodegradable polymers Biomaterials 30 2009 1176 1183
88. L.Y. Qiu, L. Yan, L. Zhang, Y.M. Jin, and Q.H. Zhao Folate-modified poly(2-ethyl-2-oxazoline) as hydrophilic corona in polymeric micelles for enhanced intracellular doxorubicin delivery Int. J. Pharm. 456 2013 315 324
89. S. Xu, and et al. Preparation and characterization of folate-chitosan-gemcitabine core-shell nanoparticles for potential tumor-targeted drug delivery J. Nanosci. Nanotechnol. 13 2013 129 138
90. X.Y. Lu, and et al. Sustained release of PI3K inhibitor from PHA nanoparticles and in vitro growth inhibition of cancer cell lines Appl. Microbiol. Biotechnol. 89 2011 1423 1433
91. S. Dedhar Integrins and signal transduction Curr. Opin. Hematol. 6 1999 37 43
92. J.S. Desgrosellier, and D.A. Cheresh Integrins in cancer: biological implications and therapeutic opportunities Nat. Rev. Cancer 10 2010 9 22
93. R. Di Toro, V. Betti, and S. Spampinato Biocompatibility and integrin-mediated adhesion of human osteoblasts to poly(DL-lactide-co-glycolide) copolymers Eur. J. Pharm. Sci. 21 2004 161 169
94. M. Pachauri, E.D. Gupta, and P.C. Ghosh Piperine loaded PEG-PLGA nanoparticles: preparation, characterization and targeted delivery for adjuvant breast cancer chemotherapy J. Drug Deliv. Sci. Technol. 29 2015 269 282
95. H. Xu, and et al. Dual-responsive mPEG-PLGA-PGlu hybrid-core nanoparticles with a high drug loading to reverse the multidrug resistance of breast cancer: an in vitro and in vivo evaluation Acta Biomater. 16 2015 156 168
96. A. Atala Re: targeted delivery of a cisplatin prodrug for safer and more effective prostate cancer therapy in vivo J. Urol. 186 2011 1553 1554
97. P.M. Valencia, and et al. Effects of ligands with different water solubilities on self-assembly and properties of targeted nanoparticles Biomaterials 32 2011 6226 6233
98. N. Jing, and D.J. Tweardy Targeting Stat3 in cancer therapy Anti-Cancer Drugs 16 2005 601 607
99. F. Danhier, and et al. Targeting of tumor endothelium by RGD-grafted PLGA-nanoparticles loaded with paclitaxel J. Control. Release 140 2009 166 173
100. N. Graf, and et al. αVβ3 integrin-targeted PLGA-PEG nanoparticles for enhanced anti-tumor efficacy of a Pt(IV) prodrug ACS Nano 6 2012 4530 4539
101. F. Huang, and et al. Self-assembled hybrid nanoparticles for targeted co-delivery of two drugs into cancer cells Chem. Commun. (Camb). 50 3103-5 2014
102. T. Loftsson, and M.E. Brewster Pharmaceutical applications of cyclodextrins: effects on drug permeation through biological membranes J. Pharm. Pharmacol. 63 2011 1119 1135
103. J. Zhang, and P.X. Ma Cyclodextrin-based supramolecular systems for drug delivery: recent progress and future perspective Adv. Drug Deliv. Rev. 65 2013 1215 1233
104. M.E. Davis, and M.E. Brewster Cyclodextrin-based pharmaceutics: past, present and future Nat. Rev. Drug Discov. 3 2004 1023 1035
105. K. Uekama, F. Hirayama, and T. Irie Cyclodextrin drug carrier systems ST - Cyclodextrin Drug Carrier Systems Chem Rev 98 1998 2045 2076
106. J.J. Yin, and et al. Synthesis and biological evaluation of novel folic acid receptor-targeted, -cyclodextrin-based drug complexes for cancer treatment PLoS ONE 8 2013
107. A. Okamatsu, and et al. Folate-appended β-cyclodextrin as a promising tumor targeting carrier for antitumor drugs in vitro and in vivo Bioconjug. Chem. 24 2013 724 733
108. F. Zhao, H. Yin, Z. Zhang, and J. Li Folic acid modified cationic -cyclodextrin-oligoethylenimine star polymer with bioreducible disulfide linker for efficient targeted gene delivery Biomacromolecules 14 2013 476 484
109. M.E. Davis, and et al. Evidence of RNAi in humans from systemically administered siRNA via targeted nanoparticles Nature 464 2010 1067 1070
110. J. Shen, and et al. Cyclodextrin and polyethylenimine functionalized mesoporous silica nanoparticles for delivery of siRNA cancer therapeutics Theranostics 4 2014 487 497
111. N.C. Bellocq, S.H. Pun, G.S. Jensen, and M.E. Davis Transferrin-containing, cyclodextrin polymer-based particles for tumor-targeted gene delivery Bioconjug. Chem. 14 2003 1122 1132
112. M.E. Davis The first targeted delivery of siRNA in humans via a self-assembling, cyclodextrin polymer-based nanoparticle: from concept to clinic Mol. Pharm. 6 2009 659 668
113. C. Park, and et al. Cyclodextrin-covered gold nanoparticles for targeted delivery of an anti-cancer drug J. Mater. Chem. 19 2009 2310
114. C. Argyo, V. Weiss, C. Bräuchle, and T. Bein Multifunctional mesoporous silica nanoparticles as a universal platform for drug delivery Chem. Mater. 26 2014 435 451
115. Y. Shi, and et al. Gefitinib loaded folate decorated bovine serum albumin conjugated carboxymethyl-beta-cyclodextrin nanoparticles enhance drug delivery and attenuate autophagy in folate receptor-positive cancer cells J. Nanobiotechnology 12 2014 1 11
116. Q. Zhou, and et al. Target-specific cellular uptake of folate-decorated biodegradable polymer micelles J. Phys. Chem. B 115 2011 12662 12670
117. R. Onodera, K. Motoyama, A. Okamatsu, T. Higashi, and H. Arima Potential use of folate-appended methyl-β-cyclodextrin as an anticancer agent Sci. Report. 3 2013 1104
118. L. Zhang, J. Lu, Y. Jin, and L. Qiu Folate-conjugated beta-cyclodextrin-based polymeric micelles with enhanced doxorubicin antitumor efficacy Colloids Surf. B: Biointerfaces 122C 2014 260 269
119. T.R. Daniels, and et al. The transferrin receptor and the targeted delivery of therapeutic agents against cancer Biochim. Biophys. Acta 1820 2012 291 317
120. C. Götz, A. Gratz, U. Kucklaender, and J. Jose TF - a novel cell-permeable and selective inhibitor of human protein kinase CK2 induces apoptosis in the prostate cancer cell line LNCaP Biochim. Biophys. Acta 1820 2012 970 977
121. F. Piazza, and et al. Protein kinase CK2 in hematologic malignancies: reliance on a pivotal cell survival regulator by oncogenic signaling pathways Leukemia 26 2012 1174 1179
122. S. Giusiano, and et al. Protein kinase CK2α subunit over-expression correlates with metastatic risk in breast carcinomas: quantitative immunohistochemistry in tissue microarrays Eur. J. Cancer 47 2011 792 801
123. B. Kaminska, and et al. Efficacy and mechanism of anti-tumor action of new potential CK2 inhibitors toward glioblastoma cells Int. J. Oncol. 35 2009 1091 1100
124. R. Hamacher, and et al. Casein kinase II inhibition induces apoptosis in pancreatic cancer cells Oncol. Rep. 18 2007 695 701
125. F. Perret, and et al. Preparation and characterization of CK2 inhibitor-loaded cyclodextrin nanoparticles for drug delivery Int. J. Pharm. 441 2013 491 498